Note: Ingredients listed on restricted chemical lists
EC/CAS
50-00-0
Name of the chemical
Formaldehyde
Concentration
N/A
General Information
Revision date
2011-06-01
Product name
Cascomel MO-608B
CAS No.
50-00-0
supplier name
Columbus OH 43215
Emergency telephone
(703) 527-3887
Icons in SDS
Company Information
company name
Momentive Specialty Chemicals Inc
e-mail address of the competent person responsible for the Safety Data Sheet
4information@momentive.com
GHS Information
Signal word
DANGER
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) Form Powder Odor Little or none OSHA/HCS status This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Emergency overview DANGER ! COMBUSTIBLE DUST WHEN FINELY DIVIDED AND SUSPENDED IN AIR. FINE DUST CLOUDS MAY FORM EXPLOSIVE MIXTURES. PRODUCT CAN EXPLODE IF DUST CLOUD IS FORMED AND IGNITED. MINIMIZE AIRBORNE DUST. PREVENT DUST ACCUMULATION. ELIMINATE ALL FIRE/IGNITION SOURCES INCLUDING STATIC DISCHARES NEAR PRODUCT/PACKAGE. REFER TO HANDLING SECTION 7 OF THE MSDS FOR MORE INFORMATION. MAY CAUSE ALLERGIC RESPIRATORY AND SKIN REACTION.
Potential Acute Health Effects
Inhalation Exposure to airborne concentrations above statutory or recommended exposure limits may cause irritation of the nose, throat and lungs. May cause sensitization by inhalation. Ingestion Not expected to be harmful under normal conditions of use. Skin May cause irritation on prolonged or repeated contact. May cause sensitization by skin contact. Eyes Exposure to airborne concentrations above statutory or recommended exposure limits may cause irritation of the eyes.
Potential chronic health
effects Some reports suggest that formaldehyde may cause respiratory sensitization, such as asthma, and that preexisting respiratory and skin disorders may be aggravated by exposure. Carcinogenicity Contains material which can cause cancer. Risk of cancer depends on duration and level of exposure. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Review Section 2 and 11 for any additional assessments. Over-exposure signs/symptoms Inhalation Adverse symptoms may include the following: respiratory tract irritation, coughing, wheezing and breathing difficulties, asthma, Ingestion No specific data. Skin Adverse symptoms may include the following: irritation, redness, Eyes Adverse symptoms may include the following: irritation, redness,
Medical Conditions Generally Aggravated by Exposure
Pre-existing respiratory and skin disorders may be aggravated by by over-exposure over-exposure to this product. See section 11 for more detailed information on health effects and symptoms.